No Data
Gansu Yatai Industrial Development (000691.SZ): Lanzhou Taihua's 3 million shares will be forcibly executed judicially.
On November 20, Gelonghui reported that gansu yatai industrial development (000691.SZ) announced that the Lanzhou Taihua, a shareholder holding over 5%, is involved in a loan contract dispute with the Gansu branch of shanghai pudong development bank. The People's Court of Chengguan District, Lanzhou City, Gansu Province, will enforce through competitive trade the 3 million shares of stocks held by Lanzhou Taihua, accounting for 0.9280% of the company's total shares.
Asia Pacific Industries: Report for the third quarter of 2024
gansu yatai industrial developent (000691.SZ) released its performance for the first three quarters, with a net loss of 21.0231 million yuan.
Gansu Yatai Industrial Development (000691.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...
Gansu Yatai Industrial Development (000691.SZ): The net loss for the first three quarters was 21.0231 million yuan.
Gelonghui, October 29 - Gansu Yatai Industrial Development (000691.SZ) announced its third quarter report for 2024, with the company achieving revenue of 0.348 billion yuan in the first three quarters, a year-on-year increase of 26.54%; net income attributable to shareholders of the listed company -21.0231 million yuan; net income attributable to shareholders of the listed company excluding non-recurring gains and losses -21.4639 million yuan; basic earnings per share -0.0650 yuan.
Gansu Yatai Industrial Development (000691.SZ): Signed a Comprehensive Strategic Cooperation Agreement with Pingshan Biomedical Research Institute of South China University of Technology.
On October 14, Gansu Yatai Industrial Development (000691.SZ) announced that, based on the principle of complementary advantages and mutual benefit, the company has formed a strategic partnership with the Pingshan Biomedical Research Institute of Southern University of Science and Technology in the commercialization of the pharmaceutical green catalysis technology platform. A cooperation agreement has been reached on the key intermediate projects, and on October 14, 2024, in Shenzhen, the "Comprehensive Strategic Cooperation Agreement" was signed, with a term of 3 years. The cooperation includes the construction of active pharmaceutical ingredient intermediate production base; the design of production lines for key chiral intermediates such as ibuprofen and tegrelor; targeting the top 200 species of active pharmaceutical ingredients globally.
Gansu Yatai Industrial Developent Co.,Ltd.'s (SZSE:000691) 26% Share Price Surge Not Quite Adding Up
Gansu Yatai Industrial Developent Co.,Ltd.'s (SZSE:000691) P/S Is Still On The Mark Following 40% Share Price Bounce
